
P030 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Maintenance in the Phase 3 True North Study
Author(s) -
Silvio Danese,
B G Feagan,
Stephen B. Hanauer,
Jovanovic Igor,
Subrata Ghosh,
AnnKatrin Petersen,
Hua Steven,
Lee Ji Hwan,
L Charles,
Denesh K. Chitkara,
Sandborn William,
Geert DʼHaens
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000722916.98351.89
Subject(s) - medicine , ulcerative colitis , clinical endpoint , maintenance therapy , placebo , surgery , randomization , clinical trial , gastroenterology , disease , chemotherapy , pathology , alternative medicine